OpGen Inc. (OPGN), now named CapForce Inc., reports developments tied to its repositioning from a precision medicine diagnostics company toward digital investment banking and financial technology. Recent company updates cover the name change, material agreements, capital actions, shareholder voting matters and governance decisions.
The company's historical news also includes operating and financial results for its former molecular diagnostics and bioinformatics business, including Unyvero systems and ARESdb-related assets. Other recurring items include reverse stock split actions, securities purchase arrangements, subsidiary insolvency developments and transitions affecting legacy commercial diagnostics operations.
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.14%
Tags
FAQ
What is the current stock price of OPGEN (OPGN)?
OPGEN (OPGN) last closed at $24.75.